Xtalks Life Science Webinars

Connected medical devices, which allow tracking of medication and communication between patient and physician, is an important and emerging technology to minimize the costs of unmanaged health conditions.

TORONTO (PRWEB)
June 26, 2020

Nearly half of all adults currently manage one or more chronic health conditions for which are no cures but are managed through daily medication and/or treatment. However, in situations where the patient is unable to successfully adhere to a medication regimen, unexpected costs of Emergency Room (ER) visits and hospitalizations may cost tens of thousands of dollars per year, per patient. According to the Journal of American Medical Association, unmanaged hypoglycemic events among diabetes patients cost over $5 Billion per year.

Connected medical devices, which allow tracking of medication and communication between patient and physician, is an important and emerging technology to minimize the costs of unmanaged health conditions. Connected devices may also be leveraged to monitor key biometrics in high-risk patient populations for injections diseases, including COVID-19. While patient acceptance of connected devices is improving, high costs associated with converting a traditional medical device to a connected medical device have remained a barrier to the adoption of this technology.

In delivering low-cost connectivity to the pharmaceutical industry, it will be possible to (i) help patients, and payers save significantly through better management of chronic health conditions, (ii) allow pharmaceutical companies to ensure patients take all medication as prescribed and (iii) assist physicians in improving patient healthcare outcomes and quality of life. Current research demonstrates that design and selection of connected health device components is a major driver in incremental costs associated with connectivity but that it is possible to drive these costs down through the selection of components that deliver value to the patient at low unit cost. Partnering with Contract Design and Manufacturing Organizations (CDMO’s) that have an integrated model of cross-functional development and manufacturing helps the pharmaceutical industry in attaining low-cost connectivity in pharmaceutical and medical devices with as little as $0.75 per unit additional cost, making connectivity an economically viable pathway for the pharmaceutical industry, patients and healthcare payers.

Join Chris Conger, Director – Connected Health Device Technology, Phillips-Medisize, in a live webinar on Wednesday, July 8, 2020, at 11 am EDT (4 pm BST/UK).

For more information or to register for this event, visit Successfully Navigating Cost Barriers to Deliver Low Cost Connectivity to the Pharmaceutical Industry.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food, and medical device community. Every year thousands of industry practitioners (from life science, food, and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends, and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

A Dynamic Framework for the Future of Human Experience

Reinforcing its commitment to elevate the human experience in healthcare, The Beryl Institute publishes the Human Experience 2030 (HX2030) vision report.

NASHVILLE, Tenn. (PRWEB)
June 26, 2020

Reinforcing its commitment to elevate the human experience in healthcare, The Beryl Institute publishes the Human Experience 2030 (HX2030) vision report. HX2030 began as a community inquiry focused on establishing fundamental actions to guide healthcare in ensuring an unwavering commitment to the human experience over the next decade.

Over 1,000 members of The Beryl Institute community provided input through a series of virtual conversations and a global survey. These concepts and ideas were reviewed by a steering team of community leaders who aligned and refined the ideas to create a dynamic framework that will be essential to elevate a commitment to human experience.

The research is grounded in three essential changes needed for healthcare transformation and three foundational needs to move toward the future of human experience. Six fundamental actions are also identified in the report, highlighting the dynamic and guiding framework for elevating human experience over the next ten years for those receiving and delivering care:

Patients and Care Partners:

1.    Reframe consumerism to patient and consumer partnership.

2.    Provide a precision experience through the use of real-time data and decision analytics.

Workforce:

3.    Address process burdens and workload issues for healthcare workers.

4.    Transform professional models for a new healthcare workforce.

Communities:

5.    Expand beyond treating illness to addressing the health and well-being of communities.

6.    Meet people where they are, where they need it and follow them where they go.

The report concludes with a depiction of how the COVID-19 pandemic and the reckoning of systemic racism in all areas of society, including healthcare, provide pressure for necessary change.

“Through this work, we have identified the ideas and actions that will not only drive our efforts, but more holistically guide us forward,” said Jason Wolf, PhD, CPXP, President & CEO of The Beryl Institute. “The future of human experience is not just a place we will eventually arrive, but rather it is an awareness of what we must do starting in this moment to lead us through the days, months and years ahead.”

To download the report and learn more about HX2030, please visit: https://www.theberylinstitute.org/HX2030

###

About The Beryl Institute:

The Beryl Institute is the global community of practice committed to elevating the human experience in healthcare. We believe human experience is grounded in experiences of patients & families, those who work in healthcare and the communities they serve. We define patient experience as the sum of all interactions, shaped by an organization’s culture, that influence patient perceptions across the continuum of care.

About InMoment:

InMoment™ helps organizations deliver more valuable and inspiring experiences to their customers, patients, and employees at every moment in their journey. Our clients gain the wisdom of our experts—who bring deep domain knowledge in experience design and delivery—coupled with our award-winning Experience Intelligence (XI)™ platform that continually analyzes and evaluates enterprise experience data and feedback. Recognized as a leader and innovator in our sector, we collaborate with the world’s leading brands to attract, engage, and retain their customers, patients, and employees. We are fiercely proud that our clients continually tell us they love the experience of working with our company, as we constantly stretch to exceed their expectations.

Share article on social media or email:

www.NAELA.org

WASHINGTON (PRWEB)
June 26, 2020

The National Academy of Elder Law Attorneys (NAELA) proudly announces that University of Richmond School of Law Professor Leigh Melton, JD; Amanda Bird, Esq.; and Lauren Ritter, Esq., are the recipients of the 2020 John J. Regan Writing Award for their article, “Observing the NOTICE Act,” published in the Spring 2019 NAELA Journal. (View PDF version of the article.)

Watch the Regan Award video.

In making the selection, the NAELA Journal editorial board members note that the article thoroughly covers Medicare’s arcane requirement of three-day inpatient admission to a hospital as a prerequisite for coverage of skilled nursing care and how this requirement continues to inflict untold financial hardship on elderly patients who have unwittingly consented to nursing home care believing it would be paid, or worse, deprived them of medically necessary care if they declined to consent knowing that Medicare would not provide coverage as a consequence of the “admission” being classified as “for observation” as opposed to “inpatient.” The article helps elder and special needs law practitioners to understand that just doing a better job of providing “notice” of the situation does nothing to remedy what is still an unacceptable situation.

The Regan Writing Award was established in 1996 in memory of John J. Regan — a long-time NAELA member and Fellow, and a pioneer in elder law — and is meant to encourage quality submissions to NAELA Journal from NAELA members and non-members.

NAELA Journal is a publication of the National Academy of Elder Law Attorneys. It covers substantive elder and special needs law topics including preservation of assets, Medicaid, Medicare, Social Security, disability, health insurance, tax planning, conservatorships, living trusts and wills, long-term care planning, housing and nursing home issues, elder abuse, fraud recovers, age discrimination, and retirement.

About NAELA

Members of the National Academy of Elder Law Attorneys (NAELA) are attorneys who are experienced and trained in working with the legal problems of aging Americans and individuals of all ages with disabilities. Upon joining, NAELA member attorneys agree to adhere to the NAELA Aspirational Standards. Established in 1987, NAELA is a non-profit association that assists lawyers, bar organizations, and others. The mission of the National Academy of Elder Law Attorneys is to educate, inspire, serve, and provide community to attorneys with practices in elder and special needs law. NAELA currently has members across the United States, Canada, Australia, and the United Kingdom. For more information, visit NAELA.org, or to locate a NAELA member in your area, visit NAELA.org/findlawyer.

# # #

Share article on social media or email:

Casebook is a cloud-based, and mobile-ready human services software.

We’ve taken over a decade of experience in child welfare, user-centered design, and best-in-class software development and turned that into an affordable SaaS solution that can bridge the technology gap facing far too many human service organizations.

NEW YORK (PRWEB)
June 26, 2020

Casebook PBC, known as a leader in child welfare software innovation, has continued its expansion across human services into four additional program areas. The New York City-based software company has been quietly developing its new platform and bringing innovation to new areas of human and social services. Casebook’s configurable Software as a Service (SaaS) platform is now bringing innovation to nonprofit and state and local government organizations in Youth & Family Services, Domestic Abuse & Victim Services, Inspection & Licensing Services, and Foster Care & Adoption Services.

“In times of crisis, such as the current pandemic, and the accompanying economic instability, there has never been a greater need to support the human services organizations and agencies that serve our country’s most vulnerable. We’ve taken over a decade of experience in child welfare, user-centered design, and best-in-class software development and turned that into an affordable SaaS solution that can bridge the technology gap facing far too many human service organizations. Organizations no longer have the luxury of months or year-long modernization projects. Human services organizations require software that is native to the domain – and even specific program areas, as well as easy to onboard and requires very minimal training for their staff. With Casebook, we are getting service organizations up and running in weeks, including importing historical data. Crises don’t honor delays, and our newest offerings are eliminating technical and programmatic obstacles so that organizations can work digitally and save time.” said Nicole Reece, Chief Product Officer.

Casebook, originally incubated by the Annie E. Casey Foundation, is a person-centric SaaS, inspired by the original version of Facebook. Purpose-built and designed to help workers, Casebook was originally designed with child welfare experts as a way to help workers prioritize and collect the data required to make informed decisions and improve outcomes. Today, Casebook PBC continues to create innovative solutions that are cloud-based, mobile-ready, and built with input from experts and workers in the program areas we support.

Share article on social media or email:

Beverly Hills Rejuvenation Center

“We are incredibly proud to be joining the Beverly Hills Rejuvenation Center family of med spas. With decades of franchising experience, we are excited to be a part of and look forward to growing with a brand like BHRC,” said co-owner, Nick Samios.

LA JOLLA, Calif. (PRWEB)
June 26, 2020

Beverly Hills Rejuvenation Center®, renown medical spa and wellness center, today announced that its newest franchised clinic will be opening in La Jolla, CA, making this the company’s 17th location nationwide. The newest Beverly Hills Rejuvenation Center is located at 909 Prospect Street #100C, La Jolla, CA 92037. The medical spa will be open July 6th, 2020.

Known for its advanced techniques and pioneering treatments, BHRC offers affordable, transformational and non-invasive services such as laser treatments, facial treatments, hormone replacement, weight loss and injectables. Other innovative treatments include Botox®, CoolSculpting®, body contouring, hair restoration and regenerative therapy.

The new med spa is owned and operated by Nicholas and Zachary Samios.

“We are incredibly proud to be joining the Beverly Hills Rejuvenation Center family of med spas. With decades of franchising experience, we are excited to be a part of and look forward to growing with a brand like BHRC. Opening our first center in La Jolla, with six more to follow in the Southern California area, will bring its state-of-the-art medical aesthetic services and second-to-none providers to an amazing market,” said co-owner, Nick Samios.

Beverly Hills Rejuvenation Center has quickly become the go-to medical spa for celebrities such as international model and star of Bravo’s “Real Housewives of Miami,” Joanna Krupa; television and film actor, Dean Cain; legendary actress, Morgan Fairchild; former Miss USA and health and fitness celebrity, Ali Landry, to name a few.

Cain has described BHRC as his “fountain of youth,” while Krupa vows Beverly Hills Rejuvenation Center is “The only place I go to look and feel great.”

The expansion in La Jolla is part of the brand’s overall franchise development plans for this year. Today, there are 16 locations open and operating in five states, with several more in various stages of development across the country.

To book a free consultation and to learn more about La Jolla’s first Beverly Hills Rejuvenation Center, visit us online at http://www.bhrcenter.com or call 619-900-BHRC (619-900-2472) for more information. Be sure to ask about opening specials!

Beverly Hills Rejuvenation Center is quickly becoming one of America’s fastest growing premier med spa and wellness center. Beverly Hills Rejuvenation Center® franchisees are experiencing rapid growth and the company is currently seeking single- and multi-unit operators to join the brand’s rapid expansion. For more information about franchise opportunities, visit Beverly Hills Rejuvenation Center® online at http://www.bhrcenter.com/medspa-franchise/.

ABOUT BEVERLY HILLS REJUVENATION CENTER

For more than 15-years, Beverly Hills Rejuvenation Center®, has been the leader in the aesthetic and wellness industries for their innovative elite health and wellness programs, customizing anti-aging therapies, cutting-edge technologies, and seasoned team of industry professionals. Currently, BHRC has 20-locations under construction or operating in key markets including Los Angeles, Newport Beach, Las Vegas, Dallas, San Antonio, Austin, Boca Raton, Chino Hills, Houston and now La Jolla.

Share article on social media or email:

Charles E. Crutchfield III, M.D.

“In our experience, although PRP and some of the other components are not yet FDA approved for Alopecia, we have a success rate of approximately 75% with our designer hair growth program. ” – Charles E. Crutchfield III, M.D.

EAGAN, Minn. (PRWEB)
June 25, 2020

Crutchfield Dermatology Announces the Successful Treatment of Hair Loss using a Novel combination of Platelet Rich Plasma, Prostaglandins, Botox, Lasers, Essential Oils, Minoxidil, Finasteride, and Scalp Conditioning Treatments.

Charles Crutchfield III M.D., a nationally recognized Board Certified Dermatologist and Clinical Professor of Dermatology, has developed a new and successful system to treat alopecia using Platelet Rich Plasma (PRP) therapy, in conjunction with several other leading-edge modalities for the treatment of hair loss and thinning hair.

As a non-surgical medical procedure to treat hair loss and thinning hair, PRP Therapy has been a well recognized successful treatment over the past several years. Charles E. Crutchfield III M.D. has seen significant results in patients seeking treatment for hair loss (Alopecia). “Using the patient’s own blood, we create a concentration of Platelet Rich Plasma to promote hair growth and rejuvenation.” Charles E. Crutchfield III M.D. explains the treatment and its benefits: “PRP therapy uses the patient’s blood to create the ideal formula of Platelet Rich Plasma. We start by drawing a blood sample and spinning the blood to separate its components: red blood cells, plasma, and platelet-rich plasma. Injecting the enriched platelet-rich plasma (containing concentrated amounts of growth factors, cytokines, and platelets), into the treatment area. This PRP treatment stimulates the inactive hair follicles into an active growth phase.”

“In addition to using PRP, we also treat the hair loss with a combination of other modalities that work synergistically. It is not “one size fits all”. We have developed a custom design a program for the patient for their maximum hair growth programs.

Crutchfield uses a combination of the following for maximal hair growth:

•     Platelet Rich Plasma (PRP)
•     Crutchfield Dermatology Hair Tonic (containing prostaglandins, finasteride, and minoxidil)
•     Botox injections
•     Hair Growth Vitamins and minerals
•     Essential Oils that promote hair growth
•     Keravive scalp conditioning treatments
•     Laser treatments for hair growth
•     Anti-inflammatory Scalp Program

We find that this combination of treatments works better than anything that we have tried in the past and we are stull refining the components.

Dr. Crutchfield has seen a significant increase in the number of patients inquiring about this therapy. Estimates are that nearly 100 million Americans suffer from hair loss. PRP for Hair Loss Therapy and the additional program of other modalities developed at Crutchfield Dermatology is a breakthrough treatment option because it is a safe, reliable treatment that is short and non-surgical. The recovery period is fast, and the results are natural.

“In our experience, although PRP and some of the other components are not yet FDA approved for Alopecia, we have a success rate of approximately 75% with our designer hair growth program.

I recommend a series of injections to be done monthly, for 4-6 months and our other programs. Once patients achieve the level of hair regrowth they are happy with, we recommend a topical treatment program to maintain and extend the PRP treatment success and recommend a PRP treatment every 6 or 12 months for maintenance. “

The hair loss and hair thinning treatment program with PRP and the other components works well for both men and women. It is primarily designed to treat androgenetic Alopecia, but we have had success in alopecia areata, scarring alopecia, and hair loss associated with stress (telogen effluvium), also.

As the testing continues and the components are adjusted, we will submit a report.

About Charles E. Crutchfield III, M.D:

Charles E. Crutchfield III, M.D., is a graduate of the Mayo Clinic Medical School and a Clinical Professor of Dermatology at the University of Minnesota Medical School. He is currently the Medical Director of Crutchfield Dermatology in Eagan and is a Benedict Distinguished Professor of Biology at Carleton College. Dr. Crutchfield has won numerous teaching and professional awards and is the co-author of a children’s book on sun protection, a dermatology textbook, and hundreds of medial articles. He is a member of the AΩA National Medical Honor Society, an expert consultant for WebMD and CNN, and a recipient of the Karis Humanitarian Award from the Mayo Clinic School of Medicine. He is the team physician for the Minnesota Twins, Vikings, Wild, Timberwolves and Lynx professional sports teams. Dr. Crutchfield has over 25 years of clinical experience caring for patients.

Share article on social media or email:

Shoe Sanitizer Mat System

There is no question that we are living in a new world where better approaches are required to protect against invisible threats. Our Shoe Sanitizer System makes it easy for workers to shield themselves from unwanted threats while giving them peace of mind.

CHICAGO (PRWEB)
June 26, 2020

NoTrax, a global leader in floor matting products, announces the launch of the Shoe Sanitizer System, a 2 or 3-zone disinfectant and sanitation mat solution that is specifically designed to prevent the spread of germs, bacteria, and viruses in the workplace and in schools.

Mark McElhinny, the President and CEO of the Justrite Safety Group, the parent company of NoTrax, said the Shoe Sanitizer System is a response to the anxieties of company leaders who want to guard their workers against viruses that we now know can easily spread via footwear making contact with heavily trafficked areas like schools, commercial lobbies, stairwells, locker rooms, airport concourses, elevator banks, and more.

“As more businesses, warehouses, factories, and other workplaces begin to open, leadership is seeking greater protection of their workforce,” said McElhinny. “Our Shoe Sanitizer System is designed to slow the potential spread of COVID-19 and any virus from spreading anywhere it shouldn’t so we can protect our co-workers and our loved ones.”

The Shoe Sanitization System’s 3-Zone system features adhesive-backed disposable carpets for quick and easy disposal.

The Zone 1 mat is a scraper mat where the footwear can be scraped of debris. The Zone 2 mat features a tray area containing a disinfectant solution. The individual sanitizes each foot simply by standing on a highly absorbent scraper mat in the tray for a few seconds until they move forward. The Zone 3 mat features an absorbent Berber carpet that dries their footwear.

It’s that quick. It’s that simple. It’s that thorough.

It’s also that essential. In fact, according to the Centers for Disease Control and Prevention, COVID-19 spread rapidly to the outside world from various floors of Huoshenshan Hospital in Wuhan, China where droplets containing the virus were discovered. In other words, hospital workers were walking the virus out the doors and into their homes and other public spaces.

“Reducing the risk of exposure to COVID-19 by cleaning and disinfection is an important part of reopening public spaces that will require careful planning,” a recent CDC reopening guide notes.

“There is no question that we are living in a new world where better approaches are required to protect against invisible threats. Our Shoe Sanitizer System makes it easy for workers to shield themselves from unwanted threats while giving them peace of mind,” said McElhinny.

About NoTrax:

NoTrax is a global leader in manufacturing a range of ergonomic, entrance, anti-fatigue, and safety mats for industrial, commercial, and food service environments. Today, NoTrax is recognized as one of the largest integrated manufacturers of floor matting products in the world. Based in Bedford Park, Illinois, NoTrax manufactures its own products in ISO certified facilities and offers global distribution capabilities with distribution centers throughout the United States and in Europe. NoTrax is a subsidiary of the Justrite Safety Group.

https://notrax.com

###

Share article on social media or email: